Contact Us
Sitemap
Home
About
Technology
Advocacy
Clinical Trials
Investors
News
Careers
Company Profile
Senior Management Team
Board of Directors
Scientific Advisory Board
Vision
Overview
Protein Misfolding & Disease
Pharmacological Chaperones
Proposed Mechanism of Action
Overview
Fabry Disease
General Disease Information
External Resources
Gaucher Disease
General Disease Information
External Resources
Pompe Disease
General Disease Information
External Resources
Pipeline
Fabry – AT1001
Gaucher – AT2101
Pompe – AT2220
Ongoing Clinical Trials
Senior Management Team
Corporate Governance
Press Releases
Events & Presentations
SEC Filings
Stock Performance
Investor FAQs
Contact Us
Press Releases
Publications & Presentations
Event Calendar
Related Articles
Overview
Career Opportunities
Benefits
Working at Amicus
Press Releases
Publications & Presentations
Event Calendar
Related Articles
Corporate Factsheet (pdf)
Programs Factsheet (pdf)
Technology Factsheet (pdf)
Information Kit (pdf)
Investors & Media
:
John Quirk
Porter Novelli Life Sciences
(212) 601-8296
Amicus in the News
Sep 22 2006
The Times (Trenton): Passion Fuels Activism: Dad, Officer, Entrepreneur
(pdf)
Aug 30 2006
The Wall Street Journal: Desperate for a Cure
(pdf)
Jan 06 2006
VentureWire (Dow Jones): Amicus Therapeutics Adds Chief Scientific Officer
Jan 2006
Venture Capital Analyst (Dow Jones): "VCs See New Disease Treatments Unfolding"
(pdf)
